Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
LenioBio Collaborates with ReciBioPharm to Scale Up ALiCE® Technology and…
This collaboration is part of the expansion in scope of LenioBio's CEPI-funded project, which aims to showcase the capacity and speed of LenioBio's proprietary ALiCE® protein expression technology to accelerate production of vaccine-relevant proteins for use in clinical trials. This project fully aligns with the 100 Days Mission spearheaded by CEPI. This collaboration is part of the expansion in scope of LenioBio's CEPI-funded project, which aims to showcase the capacity and speed of…
PR Newswire
02/10/2024
10 Clinical Posters Featuring MolecuLight Highlight its Progress Towards…
MolecuLight's showing at SAWC Fall spans a range of clinical applications and highlights new device features. These include optimized wound bed preparation ahead of skin grafting and cellular and tissue-based product (CTP) application, automatic digital wound depth measurement for streamlined workflow, thermal imaging to detect and better treat pressure injuries, associating fluorescence signals with diabetic ulcer healing, and other innovative approaches to wound care. MolecuLight's showing…
PR Newswire
02/10/2024
Mars unveils the world's largest pet parent study to better understand and serve…
With pet ownership known to be on the rise and people considering pets one of the most important things in their lives, the results signal a new era of pet parent centricity, where the emotional connection between a pet parent and their pet is stronger than ever. With pet ownership known to be on the rise and people considering pets one of the most important things in their lives, the results signal a new era of pet parent centricity, where the emotional connection between a pet parent and...
PR Newswire
02/10/2024
SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland
SyMRI 15 is a groundbreaking imaging solution that revolutionizes conventional magnetic resonance imaging (MRI) practices. Clinically validated through an extensive multi-center study involving several top-tier institutes in the United States, SyMRI 15 has demonstrated the capability to replace traditional 3D imaging techniques. The study highlighted significant enhancements in efficiency and throughput, without compromising diagnostic accuracy. SyMRI 15 is a groundbreaking imaging solution...
PR Newswire
02/10/2024
Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer
Mr. Char brings extensive experience in leading legal, compliance and corporate governance functions in successful biotech and medical device companies The appointment further expands Oculis' leadership team as the company advances its late-stage pipeline and prepares for commercial phaseOculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced the appointment of Daniel S. Char to the role...
Nasdaq GlobeNewswire
02/10/2024
Immunovia completes analytical validation of its next-generation pancreatic…
Key highlights of the analytical validation include, Key highlights of the analytical validation include, The analytical validation was conducted using an automated ELISA analyzer, which significantly enhances both performance and throughput compared to Immunovia's prior IMMray platform as well as standard manual ELISA tests. "We are happy to announce that our analytical validation results confirm the strong performance of our next-generation test. This achievement validates the...
PR Newswire
02/10/2024
Curve Therapeutics further strengthens leadership team with the appointment of…
Curve has also appointed Cora Griffin, an accomplished life sciences business development professional and entrepreneur, as Head of Business Development. Dr Griffin has considerable experience in developing and implementing portfolio strategies from start-ups to large pharmaceutical companies. She was previously Head of Business Development & Alliance Management at ReViral and was instrumental in the acquisition by Pfizer for US$525 million. Cora served as Anti-infectives Strategy Lead at…
PR Newswire
02/10/2024
LoQus23 Therapeutics announces £35 million (c.$43 million) Series A financing to…
The Mismatch Repair (MMR) branches of the DNA Damage Repair (DDR) system repair DNA insertions, deletions and misincorporation errors during transcription and/or cellular replication, with two main pathways dependent upon the size of mismatch – MutSα for small mismatches and MutSβ for larger insertion/deletion loops. The Mismatch Repair (MMR) branches of the DNA Damage Repair (DDR) system repair DNA insertions, deletions and misincorporation errors during transcription and/or cellular...
PR Newswire
02/10/2024
Nexstim Receives NBS System 5 Order from European Customer
Press release, Helsinki, 2 October 2024 at 9 AM (EEST) Nexstim Receives NBS System 5 Order from European Customer Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from an existing customer.Nexstim's NBS (Navigated Brain Stimulation) System 5 is CE marked and FDA approved for non-invasive mapping of the primary motor cortex of the brain. The system provides information that may be used in pre-procedural planning. In addition to the...
Nasdaq GlobeNewswire
02/10/2024
EssilorLuxottica Completes Acquisition of a Majority Stake in Heidelberg…
EssilorLuxottica Completes Acquisition of a Majority Stake in Heidelberg EngineeringParis, France and Heidelberg, Germany (October 2, 2024 – 7am CEST) – EssilorLuxottica, a global leader in the optical industry, announced it has completed thepreviously announcedtransaction to acquire an 80% stake in Heidelberg Engineering, a Germany-based company specializing in diagnostic solutions, digital surgical technologies and healthcare IT for clinical ophthalmology. The transaction has...
Nasdaq GlobeNewswire
02/10/2024
EssilorLuxottica Completes Acquisition of Supreme® from VF Corporation
EssilorLuxottica Completes Acquisition ofSupreme ® from VF Corporation Paris, France and Denver, Colorado (USA) (October 2, 2024 – 7am CEST)– EssilorLuxottica, a global leader in the optical industry, announced that it has successfully closed thepreviously announcedtransaction to acquire theSupreme ® brand from VF Corporation (NYSE: VFC), a global leader in branded lifestyle apparel, footwear and accessories, for an aggregate base purchase price of $1.5 billion in cash...
Nasdaq GlobeNewswire
02/10/2024
CARBIOS announces half-year 2024 financial results and presents its industrial…
Construction progress of world's first PET enzymatic biorecycling plant in France: in line with production targets in 2026Commercial development: several Letters of Intent signed in view of licensing agreementsConsolidated cash position of €120.7 million on 30 June 2024, plus €23.4 million in term deposits classified as financial assets. In addition, €42.5 million in public funding is expected. Clermont-Ferrand (France), Wednesday 02 October 2024 (6:45am CEST). CARBIOS,...
Nasdaq GlobeNewswire
02/10/2024
PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight
Key Takeaways from the PLK-1 Inhibitors Market Report Key Takeaways from the PLK-1 Inhibitors Market Report Discover which therapies are expected to grab the PLK-1 inhibitors market share @ PLK-1 Inhibitors Market Report PLK-1 Inhibitors Market Dynamics The PLK-1 inhibitors market is a rapidly evolving sector within the oncology pharmaceutical landscape. One of the primary drivers of the PLK-1 inhibitors market is theincreasing prevalence of cancerand thedemand for more...
PR Newswire
01/10/2024
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
The Grants were offered as material inducement to the employees' employment. The grants were approved by the Compensation Committee of the Company's Board of Directors pursuant to the Company's Inducement Plan to motivate and reward the recipients to perform at the highest levels and contribute significantly to the success of the Company. The Grants were made in reliance on the employment inducement exemption under the NYSE's Listed Company Manual Rule 303A.08.The Company is issuing this...
Nasdaq GlobeNewswire
01/10/2024
IBA - Regulated Information
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)Louvain-la-Neuve, Belgium, October 1st, 2024 06:00 Summary of the notificationIBA (Ion Beam Applications), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification...
Nasdaq GlobeNewswire
01/10/2024
LAPSI HEALTH'S KEIKKU GETS FDA CLASS II CLEARANCE AND LAUNCHES IN THE U.S. WITH…
Lapsi means 'child' in Finnish (As the company has Dutch-Finnish roots), Keikku means 'tool'. Lapsi means 'child' in Finnish (As the company has Dutch-Finnish roots), Keikku means 'tool'. Dr.Diana van Stijn, MD, Chief Medical Officer of Lapsi Health, emphasizes the disruptive potential of Keikku: "Sound has always been key in diagnostics, but with Keikku, we're turning it into actionable data that can revolutionize and empower medical care." Unlike traditional stethoscopes, Keikku...
PR Newswire
01/10/2024
China Neurogenomics Market to Reach $562.1 Million by 2031 - Exclusive Report by…
Download FREE PDF Brochure Of China Neurogenomics Market –https://www.meticulousresearch.com/product/china-neurogenomics-market-6003 Download FREE PDF Brochure Of China Neurogenomics Market – https://www.meticulousresearch.com/product/china-neurogenomics-market-6003 The growth of this market is driven by the declining costs of sequencing, the increasing prevalence of neurological disorders, the growing utilization of advanced sequencing technologies in disease diagnostics &...
PR Newswire
01/10/2024
Sleep Apnea Oral Appliances Market to Hit USD 746.6 Million by 2029 with 9.6%…
Browse in-depth TOC on "Sleep Apnea Oral Appliances Market" Browse in-depth TOC on "Sleep Apnea Oral Appliances Market" 295 - Tables 45 - Figures 287 - Pages The global sleep apnea oral appliances market is bringing new advancements in the mandibular advancement devices. More innovations are being done on the mandibular advancement devices for making it custom fit for the users, custom made devices are made to made to provide durability and comfort. Glidewell (US) launched…
PR Newswire
01/10/2024
Conformal Medical Announces Launch of the GLACE Study with Next-Gen CLAAS®…
Initial patients were treated by the study's co-principal investigators Professor Jens Erik Nielsen-Kudsk, M.D. of Aarhus University Hospital and Professor Ole De Backer, M.D. of Rigshospitalet, Copenhagen University Hospital at their respective institutions in Denmark. Additionally, Shephal Doshi, M.D., from Providence Saint John's Health Center and the Pacific Heart Institute in Santa Monica, California and Principal Investigator of the CONFORM Pivotal Trial was present for the initial cases…
PR Newswire
01/10/2024
PeptiGrowth Inc. is Launching a Novel Synthetic FGF2 Alternative Peptide (FGFR1c…
Traditional growth factors and cytokines used in regenerative medicine and cell therapy manufacturing face several quality issues, including lot-to-lot variability, potential contamination with biological impurities, low stability, and high costs. PeptiGrowth has focused on developing a series of synthetic peptides that address these challenges while maintaining functionality equivalent to conventional growth factors and cytokines. Their peptides are completely chemically synthesized and free…
PR Newswire
01/10/2024
Mölnlycke® Health Care acquires P.G.F. Industry Solutions GmbH, the manufacturer…
"The acquisition of P.G.F. will allow Mölnlycke to expand our Granudacyn business and further develop our growing wound care portfolio. Granudacyn effectively cleanses wounds, which supports healing, ultimately helping to ease the burden of wounds" says Zlatko Rihter, CEO of Mölnlycke Health Care. "The acquisition of P.G.F. will allow Mölnlycke to expand our Granudacyn business and further develop our growing wound care portfolio. Granudacyn effectively cleanses wounds, which…
PR Newswire
01/10/2024
Teva Announces Launch of the First and Only Generic Version of Sandostatin® LAR…
This first-to-market launch showcases Teva's proven strengths in complex generic formulations andenhancesTeva's strategic goal of sustaining a generic powerhouse . Octreotide acetate for injectable suspension is indicated to treat acromegaly and severe diarrhea for carcinoid syndrome .PARSIPPANY, N.J., Oct.01, 2024(GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the...
Nasdaq GlobeNewswire
01/10/2024
ClariMed Inc. Strengthens Leadership Team with Joe Dobkin as New VP of Services
In his new role as Vice President of Services, Dobkin will spearhead service delivery, optimize processes, and help expand ClariMed's offerings to better serve clients. Known for his thoughtful approach, attention to detail, and calm presence, Dobkin's leadership style aligns well with ClariMed's cultural values. His initial focus will be on learning about ClariMed's people and processes, setting a strong foundation for future growth and optimization. In his new role as Vice President of...
PR Newswire
01/10/2024
Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer…
Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of177 Lu-PSMA-I&T and64 Cu-PSMA-I&TBuilds on long-standing relationship between the two companiesIn Japan around 90,000 new cases of prostate cancer are diagnosed each year PARIS, Oct.01, 2024(GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has entered into a strategic partnership with PDRadiopharma Inc, a wholly-owned subsidiary of...
Nasdaq GlobeNewswire
01/10/2024
Altri Comunicati
